Assessing Potential Implications of New Data on CMV Treatment in Transplant Recipients

Program Overview

The management of cytomegalovirus (CMV) infection or disease in transplant patients has historically been challenging due to side effects with older antiviral therapies, including myelotoxicity and renal toxicity. Side effect and efficacy data for newer improved transplant antiviral therapies, including maribavir and letermovir, is emerging rapidly. The goal of this activity is to help you learn about the emerging data and how to apply it in clinical practice when managing your transplant patients.

0.5 CE Credit(s)
Expires: December 13, 2023

Target Audience

Infectious disease, nephrology, and transplantation clinicians and pharmacists who provide care for transplant patients with cytomegalovirus (CMV) infection.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Employ late-breaking data on the efficacy of available antiviral therapies when managing cytomegalovirus (CMV) in solid organ transplant (SOT) patients
  • Utilize new data on the safety and tolerability of available antiviral therapies for CMV management in the SOT setting

Activity Faculty

Camille Kotton portrait 2021

Camille Nelson Kotton, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, United States


Atul Humar, MD, MSc, FRCPC, FAST

Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, Ontario, Canada


Provider Statement

This activity is provided by RMEI Medical Education, LLC.

Supporter Statement

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Disclosure of Financial Relationships 

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 


Camille Nelson Kotton, MD, FIDSA, FAST, has relevant financial relationships with Biotest, Evrys, Exevir, Hookipa, Merck, Oxford Immunotec, Roche Diagnostics, Takeda (Consultant).

Atul Humar, MD, FRCPC, FAST, has relevant financial relationships with Astellas Pharma, Inc., Roche, Takeda (Consultant).

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.

Accreditation Statement 

 In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

For Physicians
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses 
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.50 contact hour(s).

For Pharmacists 
RMEI Medical Education, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number – JA4008290-0000-22-006-H01-P)
Type of Activity: Knowledge

Instructions for Participation and Credit 

Method of Participation
To receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation

There is no fee to participate.



*The expense for this gift card is solely funded by RMEI Medical Education, LLC. 
No supporter funding was used for the expense of this gift card. 

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.   

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2023. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources